<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2024, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 23 Jan 2024 16:06:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  8-K/A      Cartesian Therapeutics,   For: Nov 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</guid>
   <pubDate>Tue, 23 Jan 2024 16:06:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K/A      Cartesian Therapeutics,   For: Nov 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</guid>
   <pubDate>Tue, 23 Jan 2024 16:06:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K/A      Cartesian Therapeutics,   For: Nov 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Cartesian+Therapeutics%2C+++For%3A+Nov+13/22662584.html</guid>
   <pubDate>Tue, 23 Jan 2024 16:06:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</guid>
   <pubDate>Fri, 19 Jan 2024 16:13:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</guid>
   <pubDate>Fri, 19 Jan 2024 16:13:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+17/22651509.html</guid>
   <pubDate>Fri, 19 Jan 2024 16:13:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  S-8        Cartesian Therapeutics,              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</guid>
   <pubDate>Fri, 12 Jan 2024 16:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  S-8        Cartesian Therapeutics,              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</guid>
   <pubDate>Fri, 12 Jan 2024 16:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  S-8        Cartesian Therapeutics,              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Cartesian+Therapeutics%2C++++++++++++++/22628317.html</guid>
   <pubDate>Fri, 12 Jan 2024 16:16:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 08</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</guid>
   <pubDate>Mon, 08 Jan 2024 08:46:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 08</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</guid>
   <pubDate>Mon, 08 Jan 2024 08:46:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Form  8-K        Cartesian Therapeutics,   For: Jan 08</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cartesian+Therapeutics%2C+++For%3A+Jan+08/22605538.html</guid>
   <pubDate>Mon, 08 Jan 2024 08:46:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Cartesian+Therapeutics+Highlights+Progress+and+2024+Strategic+Priorities+Across+Innovative+Pipeline+of+mRNA+Cell+Therapies+for+Autoimmunity/22604600.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:10:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04856707</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics (RNAC) Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis</title>
   <link>http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:03:04 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics (RNAC) Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis</title>
   <link>http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:03:04 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
  <item>
   <title>Cartesian Therapeutics (RNAC) Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis</title>
   <link>http://www.streetinsider.com/FDA/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Cartesian+Therapeutics+%28RNAC%29+Announces+Positive+Long-Term+Follow-Up+Data+from+Phase+2a+Study+of+Lead+mRNA+Cell+Therapy+Candidate+Descartes-08+in+Patients+with+Myasthenia+Gravis/22604535.html</guid>
   <pubDate>Mon, 08 Jan 2024 07:03:04 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RNAC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SELB</category>
   	  </item>
 </channel>
</rss>
